UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031623 |
|---|---|
| Receipt number | R000035817 |
| Scientific Title | Phase II Study of Crizotinib in Japanese Patients with Advanced MET exon14 skipping mutation-positive or MET high gene copy number-positive non-small cell lung cancer |
| Date of disclosure of the study information | 2018/03/20 |
| Last modified on | 2021/10/08 12:20:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/03/07 14:05:40 | ||
| 2 | Update | 2018/03/26 11:17:43 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2019/03/07 18:09:42 | Email Email1 |
|
| 4 | Update | 2019/09/09 15:14:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 5 | Update | 2019/09/09 15:16:25 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2021/10/08 12:20:03 | Recruitment status |
